Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial
Hoffmann-La Roche
Jens Huober; Carlos H Barrios; Naoki Niikura; Michał Jarząb; Yuan-Ching Chang; Shannon L Huggins-Puhalla; José Pedrini; Lyudmila Zhukova; Vilma Graupner; Daniel Eiger; Volkmar Henschel; Nino Gochitashvili; Chiara Lambertini; Eleonora Restuccia; Hong Zhang; IMpassion050 Trial Investigators